Navigation Links
Pharmaceutical Industry Insiders, VIPs All Coming Together for Future of Pharma Market, Pharmaceutical Competitive Intelligence
Date:9/8/2010

PARSIPPANY, N.J., Sept. 8 /PRNewswire/ -- Today every major pharmaceutical industry executive searches for ways to succeed when looking toward the future of pharma.  In an unprecedented move, they're all coming together in just a few weeks.  All the big names in pharma.  All in one place.  That's the scene you'll find on September 21-22, 2010 at the Pharma CI Conference & Exhibition at the Hilton Parsippany Hotel in Parsippany, New Jersey, USA.  In fact, more than 250 pharma thought leaders have already signed up.  And with each day, more people say they want to be part of this historic, high quality event.  To see who's coming so far, go to www.Pharmaciconference.com/attendees.html.

This comprehensive conference is geared toward anyone who has a stake in the pharmaceutical marketplace.  It's truly an eye-opening experience for anyone interested in what happens next for pharma giants, as well as up-and-comers.

Pharmaceutical decision makers say they want the most accurate and up-to-date information about the pharma industry, especially pharmaceutical competitive intelligence.  It's the kind of data only true experts can provide.  And these experts are all coming to the Pharma CI Conference & Exhibition.   More than 75 preeminent speakers will delve into current and future hot topics.  To see the speaker list, go to www.Pharmaciconference.com/speakers.html.

The Pharma CI Conference is the industry's gold standard for senior level pharma, biotech, and medical device professionals seeking the latest in competitive intelligence and business intelligence.  

Highlights:

  • Unparalleled Networking: Meet hundreds of peers in just two days.
  • Superior Speakers: 75+ senior level speakers with depth of knowledge found nowhere else.  
  • Expansive Coverage: 50+ sessions (presentations, panel and roundtable discussions, and workshops) cover every important topic.

2010 sponsors/exhibitors include:

Fletcher/CSI, Deallus, Fuld & Company, Applied Intelligence, Aurora WDC, BCC Research, Best Practices, BioMedTracker, Brady Corp, Capital IQ, CBR Pharma Insights, Digimind, Dow Jones, dtw, Dunn Group, EvaluatePharma, Evalueserve, Financial Times, FirstWord, Indegene, Larvol Group, Lifescience Dynamics, MedPredict, Murray Hill Center, Northern Light, PharmaForce, PharmaVoxx, Prescient Life Sciences, Proactive Worldwide, research reporter, SAI MedPartners, Search Technology, Sedulo Group, ValueCentric, and Wolters Kluwer Pharma Solutions.  

For more information or registration, go to www.Pharmaciconference.com, call 212.228.7974/713.398.6888 or email info@pharmaciconference.com.


'/>"/>
SOURCE Pharma CI Conference
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
8. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... - Medicure Inc. ("Medicure") (TSXV:MPH, OTC:MCUJF), a specialty pharmaceutical ... ended December 31, 2016 after market close on ... released later than the previous fiscal year,s results ... and balances of Apicore from the acquisition date ... date meets TSX Venture Exchange listed company requirements. ...
(Date:3/28/2017)... 28, 2017 "Chemotherapy Induced Neutropenia (CIN) – Market Insights, ... and global market trends of the Chemotherapy Induced Neutropenia for the ... Europe ( France , ... , UK) and Japan , as well ... of the world (RoW). The Report covers the therapeutics ...
(Date:3/28/2017)... March 28, 2017  "US Cancer Generics Market ... various indicators and trend analysis related to the ... mainstream pharmaceutical market in US. The report analyzes ... growth on cancer generics drugs in recent years. ... of billions of dollars for various stake holders ...
Breaking Medicine Technology:
(Date:3/29/2017)... PITTSBURGH, PA (PRWEB) , ... March 29, 2017 ... ... and hassles associated with wearing oral braces. "The rubber bands used in conjunction ... he said, "so I decided to design a way to prevent this problem." ...
(Date:3/29/2017)... , ... March 29, 2017 ... ... and South Hills of Pittsburgh now have easier access to the robotic-assisted ... by Allegheny Health Network (AHN). Orthopaedic surgeons at Forbes Hospital and Jefferson ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... in order to improve teacher quality, the field must first improve teacher preparation ... popular reform to the next” and that decades of input- and outcome-based research ...
(Date:3/28/2017)... ... March 28, 2017 , ... Resoundant, Inc., the developer ... the Siemens Healthineers annual customer education symposium, a world-class learning conference that offers ... March 27 - 31, 2017 at the Atlanta Marriott Marquis in Atlanta, Georgia. ...
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... ... management software and services, is proud to announce it has joined the National ... association representing the interests of chronically ill, disabled, and dying Americans of all ...
Breaking Medicine News(10 mins):